General Motors
GM
$76.07
-2.12%
General Motors is a global automotive manufacturer operating through GM North America, GM International, and GM Financial, designing, building, and selling vehicles under brands including Chevrolet, GMC, Cadillac, and Buick. As the US market share leader with 17.4% in 2025, GM is a dominant incumbent in the traditional auto industry, but is also pivoting toward electric vehicles and autonomous driving through its wholly-owned Cruise subsidiary. The current investor narrative centers on GM's ability to defend its profitable truck franchise against cyclical demand headwinds, while simultaneously funding a costly EV transition and navigating the aftermath of Cruise's 2023 accident, which shifted its AV strategy from robotaxis to personal autonomous vehicles.…
GM
General Motors
$76.07
Related headlines
GM 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on General Motors's 12-month outlook, with a consensus price target around $95.85 and implied upside of +26.0% versus the current price.
Average Target
$95.85
0 analysts
Implied Upside
+26.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$60 - $131
Analyst target range
GM is covered by 26 analysts, with a consensus recommendation of 'Buy' (mean rating 1.89 on a 1-5 scale where 1 is Strong Buy). The average price target is $95.85, implying 23.4% upside from the current price of $77.64. The distribution shows a bullish lean, with no 'Sell' ratings among the recent institutional ratings from RBC Capital, JP Morgan, Citigroup, Wedbush, and Evercore ISI, all maintaining Outperform or Buy ratings. The lone bearish voice is Wells Fargo with an Underweight rating, but the overall sentiment is positive. The target range spans from a low of $60.00 to a high of $131.00, a spread of $71 or 118% of the current price, indicating significant uncertainty about GM's future. The high target of $131 assumes a successful EV transition, margin expansion from software and autonomous driving, and multiple expansion, while the low target of $60 prices in a recession, loss of market share, and failure to achieve profitability in new ventures. Recent analyst actions show no downgrades, with firms like RBC Capital and JP Morgan reaffirming their positive ratings in July 2026, suggesting conviction in the near-term outlook. The wide target spread reflects the binary nature of GM's transformation story, where outcomes range from a highly profitable tech-enabled automaker to a legacy player facing structural decline.
Drowning in data?
Find the real signal!
Bulls vs Bears: GM Investment Factors
GM presents a classic value-versus-value-trap debate. On the bull side, a forward P/E of 5.48x, strong FCF of $12.48B, and analyst consensus Buy with 23% upside paint a compelling deep-value picture. On the bear side, trailing P/E of 24.4x, revenue stagnation, high leverage, and negative price momentum raise red flags. The single most important tension is whether GM can deliver the consensus EPS of $14.09 in the coming year—if it does, the stock is deeply undervalued; if it misses due to cyclical pressures or EV transition costs, the forward multiple could expand as earnings fall. Currently, the bull case has stronger evidence given the extreme forward multiple discount and analyst support, but the bear risks are non-trivial.
Bullish
- Deep Value on Forward P/E: GM's forward P/E of 5.48x is a steep discount to the auto industry average of 10-12x, implying the market is pricing in significant earnings risk. If consensus EPS of $14.09 materializes, the stock would be deeply undervalued, offering substantial upside.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow is $12.48 billion, providing ample liquidity to fund EV investments, buybacks, and dividends. Q1 2026 FCF of $1.44 billion demonstrates continued cash generation despite revenue headwinds.
- Analyst Consensus Buy with 23% Upside: 26 analysts rate GM a Buy with a mean rating of 1.89/5. The average price target of $95.85 implies 23.4% upside from $77.64. No Sell ratings from major firms like RBC, JPM, and Citi reinforce institutional confidence.
- Market Share Gains from Ford Weakness: GM is strategically ramping truck production to capitalize on Ford's aluminum supply disruptions, creating a near-term opportunity to gain market share in the profitable full-size truck segment. This could boost Q2/Q3 2026 results.
Bearish
- Trailing P/E Elevated at 24.4x: The trailing P/E of 24.42x is near the top of its 5-year range of 3.5x-12x, making the stock look expensive on past earnings. The Q4 2025 loss of $3.31 billion depressed trailing earnings, inflating the multiple.
- Revenue Stagnation and Margin Pressure: Q1 2026 revenue of $43.62 billion was down 0.9% YoY, and gross margin fell to 11.45% from 12.13% a year ago. Operating margin compressed to 6.71% from 7.62%, indicating cost pressures or unfavorable mix.
- High Debt-to-Equity of 2.13: GM's debt-to-equity ratio of 2.13 is elevated for an industrial company, signaling significant leverage. While FCF covers debt service, a recession or prolonged downturn could strain the balance sheet.
- Negative PEG Ratio Reflects Earnings Risk: The PEG ratio of -0.50 is negative due to expected earnings decline, complicating the growth-adjusted valuation. This implies the market does not believe current earnings are sustainable.
GM Technical Analysis
GM is in a broad uptrend over the past year, with the stock up 47.3% from 12 months ago, but has pulled back sharply from its 52-week high of $87.62. The current price of $77.64 sits at 88.6% of the 52-week range, indicating the stock is still in the upper half but has lost momentum after peaking in late May. This positioning suggests the market is reassessing near-term catalysts after a strong run, but the longer-term trend remains positive. The 1-month price change of -7.65% and 3-month change of -0.53% contrast sharply with the 1-year gain, signaling a clear deceleration in momentum. The 1-month relative strength vs. SPY is -8.25%, meaning GM has underperformed the market by over 8 percentage points in the last month, a bearish divergence that often precedes further downside or a mean-reversion bounce. The stock's beta of 1.309 implies it is 30.9% more volatile than the S&P 500, amplifying both upside and downside moves. Key support lies at the 52-week low of $48.87, while resistance is at the 52-week high of $87.62. A break above $87.62 would signal a resumption of the uptrend, while a fall below the recent June lows near $77 could test the $72 area. The elevated volatility (beta >1.3) means position sizing should be conservative in a portfolio context.
Beta
1.31
1.31x market volatility
Max Drawdown
-16.2%
Largest decline past year
52-Week Range
$49-$88
Price range past year
Annual Return
+43.0%
Cumulative gain past year
| Period | GM Return | S&P 500 |
|---|---|---|
| 1m | -4.4% | +0.3% |
| 3m | -6.5% | +4.7% |
| 6m | -5.9% | +7.5% |
| 1y | +43.0% | +18.4% |
| ytd | -6.1% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
GM Fundamental Analysis
GM's revenue trajectory is showing signs of stagnation, with Q1 2026 revenue of $43.62 billion down 0.9% year-over-year, following a pattern of flat to slightly declining top-line growth over the past four quarters (Q2 2025: $47.12B, Q3 2025: $48.59B, Q4 2025: $45.29B). The core GM North America segment generated $36.40 billion in Q1 2026, while GM Financial contributed $4.28 billion, indicating the traditional auto business remains the primary revenue driver. The lack of growth raises questions about GM's ability to expand in a mature market, though the company is strategically ramping truck production to capitalize on Ford's supply disruptions, which could provide a temporary boost. Profitability has been inconsistent: Q1 2026 net income was $2.63 billion with a gross margin of 11.45%, a recovery from Q4 2025's loss of $3.31 billion (gross margin -2.48%), but below the 12.13% gross margin in Q1 2025. The operating margin of 6.71% in Q1 2026 is healthy but compressed versus the 7.62% in the year-ago quarter, suggesting cost pressures or mix shifts. The net margin of 6.02% is decent for an automaker, but the Q4 2025 loss highlights the earnings volatility inherent in the business, driven by restructuring charges and Cruise impairments. GM's balance sheet shows a debt-to-equity ratio of 2.13, which is elevated for an industrial company, indicating significant leverage. However, free cash flow generation is strong: trailing twelve-month FCF is $12.48 billion, and Q1 2026 FCF was $1.44 billion, providing ample liquidity to fund investments and buybacks. The current ratio of 1.17 suggests adequate short-term liquidity, while ROE of 4.41% is modest, reflecting the high equity base relative to earnings. The company's ability to generate cash despite cyclical headwinds is a key credit positive.
Quarterly Revenue
$43.6B
2026-03
Revenue YoY Growth
-0.9%
YoY Comparison
Gross Margin
11.5%
Latest Quarter
Free Cash Flow
$12.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is GM Overvalued?
Since net income is positive (TTM net income of $2.63 billion in Q1 2026), the primary valuation metric is the P/E ratio. The trailing P/E stands at 24.42x, while the forward P/E is just 5.48x, an enormous gap that implies the market expects a dramatic earnings rebound in the coming year. This forward multiple is extremely low, suggesting deep value territory if earnings materialize, but the trailing multiple is elevated due to the Q4 2025 loss that depressed trailing earnings. Compared to the auto industry average P/E of roughly 10-12x, GM's trailing P/E of 24.42x appears expensive, but the forward P/E of 5.48x is a steep discount, reflecting the market's skepticism about earnings sustainability. The PEG ratio is negative (-0.50) due to negative earnings growth expectations, which complicates the growth-adjusted valuation picture. Historically, GM's trailing P/E has ranged from 3.5x to 12x over the past five years, with the current 24.42x near the top of that band, indicating the stock is expensive on a trailing basis relative to its own history. However, the forward P/E of 5.48x is near the low end of historical forward multiples, suggesting that if the company delivers on consensus EPS estimates of $14.09, the stock would be cheap. The P/S ratio of 0.40x is below the 5-year average of ~1.5x, reinforcing the value narrative from a sales perspective.
PE
24.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 3x~12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: GM's balance sheet carries a debt-to-equity ratio of 2.13, which is high for an industrial company and exposes it to rising interest costs (Q1 2026 interest expense was $158M). The Q4 2025 net loss of $3.31 billion, driven by restructuring and Cruise impairments, highlights earnings volatility. Revenue has stagnated, with Q1 2026 down 0.9% YoY, and gross margin compressed to 11.45% from 12.13% a year ago. The company's reliance on high-margin truck sales (17.4% US market share) makes it vulnerable to any shift in consumer demand away from full-size vehicles.
Market & Competitive Risks: GM's beta of 1.309 implies 30.9% higher volatility than the market, amplifying downside in a selloff. The stock's trailing P/E of 24.4x is near the top of its 5-year range, suggesting valuation compression risk if earnings disappoint. Competitive threats include Ford's recovery from supply issues (aluminum restart in June 2026) and Tesla's dominance in EVs. Regulatory risks include tightening fuel economy standards and potential tariffs on imported components. Recent news highlights rising fuel costs pressuring demand for Detroit's high-margin trucks, a key profit engine.
Worst-Case Scenario: A recession combined with a failure to execute the EV transition could trigger a severe earnings decline. If GM reports a loss similar to Q4 2025's -$3.31B, the stock could fall to its 52-week low of $48.87, representing a 37% decline from the current $77.64. In a prolonged downturn, the stock could test even lower levels, with the analyst low target of $60 implying a 23% drop. Historical max drawdown of -16.2% suggests a more moderate risk, but the high beta amplifies tail risk.
